VOLITIONRX LTD Logo

VOLITIONRX LTD

Develops epigenetic blood tests for early cancer and sepsis detection in human/veterinary markets.

VNRX | US

Overview

Corporate Details

ISIN(s):
US9286611077
LEI:
Country:
United States of America
Address:
1489 WEST WARM SPRINGS ROAD, 89014 HENDERSON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

VolitionRx Ltd. is a multi-national epigenetics company that develops and commercializes blood-based diagnostic tests for the early detection and monitoring of life-altering diseases. The company's core technology is its proprietary Nu.Q® platform, a nucleosome quantification technology that detects epigenetic biomarkers in circulating chromatin. This platform enables the creation of simple, cost-effective, and non-invasive assays. Volition's primary applications are in oncology and sepsis for both the human and veterinary markets. The company's goal is to improve outcomes by enabling earlier diagnosis, monitoring disease progression, and evaluating treatment responses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VOLITIONRX LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VOLITIONRX LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VOLITIONRX LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Perseus Proteomics Inc. Logo
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
Japan
4882
Personalis, Inc. Logo
Cancer genomics & liquid biopsy for early recurrence detection & guiding precision therapies.
United States of America
PSNL
Perspective Therapeutics, Inc. Logo
Developing targeted alpha radiotherapies using lead-212 to image and treat solid tumors.
United States of America
CATX
PharmAbcine Inc. Logo
Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.
South Korea
208340
Pharma Foods International Co., Ltd. Logo
Researches and sells functional ingredients and direct-to-consumer health & beauty products.
Japan
2929
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain
PHM
Pharmanutra Logo
Researches and markets nutritional supplements & medical devices for all ages.
Italy
PHN
PHARMARESEARCH BIO Co., Ltd. Logo
A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.
South Korea
217950
PharmaResearch Co., Ltd. Logo
Develops regenerative medicine, devices & cosmetics using marine biotechnology.
South Korea
214450
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany
PSG

Talk to a Data Expert

Have a question? We'll get back to you promptly.